Finance

Lists
OCUL:NASDAQ
Ocular Therapeutix Inc
၇.၅၅ US$
+၀.၅၃%
(+၀.၀၄၀) 1D
အောက် ၉, GMT-၄ ၁၅:၀၂:၃၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
၇.၄၉ US$
High
၇.၆၈ US$
Low
၇.၃၈ US$
Mkt. cap
၁၆၅.၈၁ ဋေ
Avg. vol.
၃.၂၀ သန်း
Volume
၁.၆၀ သန်း
52-wk high
၁၆.၄၄ US$
52-wk low
၆.၂၃ US$
EPS
-၁.၄၁ US$
Beta
၁.၀၀
Shares outstanding
၂၁.၉၆ ကုဋေ
No. of employees
၃၂၅
Open
၇.၄၉ US$
High
၇.၆၈ US$
Low
၇.၃၈ US$
Mkt. cap
၁၆၅.၈၁ ဋေ
Avg. vol.
၃.၂၀ သန်း
Volume
၁.၆၀ သန်း
52-wk high
၁၆.၄၄ US$
52-wk low
၆.၂၃ US$
EPS
-၁.၄၁ US$
Beta
၁.၀၀
Shares outstanding
၂၁.၉၆ ကုဋေ
No. of employees
၃၂၅
News stories
From web sources and news partners
The Manila Times
The Manila Times
·
ပြီးခဲ့သည့် ၇ နာရီ
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၈ နာရီ
15 new hires receive stock awards from Ocular Therapeutix
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၂၂ နာရီ
Officer Todd Anderman proposes selling 11,984 shares of Ocular Therapeutix (OCUL).
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees၃၂၅
Founded၂၀၀၆
HeadquartersBedford, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteocutx.com
Analyst ratings
Based on 8 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current ၇.၅၅ US$
၃၁.၀၀ US$ (+၃၁၀.၆၀%)
Average
၂၅.၅၇ US$ (+၂၃၈.၆၈%)
Lowest
၁၈.၀၀ US$ (+၁၃၈.၄၁%)
Analyst
Recommendation
Action
Price target
Projected
Date
Biren Amin
Piper Sandler
Buy
Maintained
၃၁.၀၀ US$
+၃၁၀.၆%
09/29/2026
Serge Belanger
Needham
Buy
Maintained
၁၈.၀၀ US$
+၁၃၈.၄%
09/28/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/25/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
၂၅.၀၀ US$
+၂၃၁.၁%
09/16/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
၂၇.၀၀ US$
+၂၅၇.၆%
09/15/2026
William Maughan
Clear Street
Buy
Reiterated
၂၈.၀၀ US$
+၂၇၀.၉%
08/18/2026
Tara Bancroft
TD Cowen
Buy
Maintained
၂၀.၀၀ US$
+၁၆၄.၉%
08/03/2026
Lisa Walter
RBC Capital
Buy
Maintained
၃၀.၀၀ US$
+၂၉၇.၄%
08/03/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
၂၃.၀၀ US$
+၂၀၄.၆%
06/25/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
၃၀.၀၀ US$
+၂၉၇.၄%
06/18/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
၂၈.၀၀ US$
+၂၇၀.၉%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၄၅ ကုဋေ
၁.၃၂ ကုဋေ
၁.၀၈ ကုဋေ
၁.၃၅ ကုဋေ
Cost of goods sold
၅.၄၁ ကုဋေ
၅.၂၄ ကုဋေ
၆.၇၅ ကုဋေ
၅.၆၁ ကုဋေ
Cost of revenue
၅.၄၁ ကုဋေ
၅.၂၄ ကုဋေ
၆.၇၅ ကုဋေ
၅.၆၁ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၉၁ ကုဋေ
၃.၀၆ ကုဋေ
၃.၆၆ ကုဋေ
၃.၉၄ ကုဋေ
Operating expense
၂.၉၁ ကုဋေ
၃.၀၆ ကုဋေ
၃.၆၆ ကုဋေ
၃.၉၄ ကုဋေ
Total operating expenses
၈.၃၂ ကုဋေ
၈.၃၀ ကုဋေ
၁၀.၄၁ ကုဋေ
၉.၅၆ ကုဋေ
Operating income
-၆.၈၇ ကုဋေ
-၆.၉၈ ကုဋေ
-၉.၃၃ ကုဋေ
-၈.၂၁ ကုဋေ
Other non operating income
-၁.၄၅ သန်း
၆.၂၄ သိန်း
၁.၄၆ သန်း
၆.၈၉ သိန်း
EBT including unusual items
-၆.၉၄ ကုဋေ
-၆.၄၇ ကုဋေ
-၈.၈၆ ကုဋေ
-၇.၈၈ ကုဋေ
EBT excluding unusual items
-၆.၉၄ ကုဋေ
-၆.၄၆ ကုဋေ
-၈.၈၆ ကုဋေ
-၇.၈၈ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၆.၉၄ ကုဋေ
-၆.၄၇ ကုဋေ
-၈.၈၆ ကုဋေ
-၇.၈၈ ကုဋေ
Net profit margin
-၄၇၇.၃၀%
-၄၈၇.၉၅%
-၈၂၁.၆၂%
-၅၈၄.၅၁%
Earnings per share
-၀.၃၈
-၀.၂၉
-၀.၄၀
-၀.၃၅
Interest and investment income
၃.၇၃ သန်း
၇.၃၄ သန်း
၆.၀၅ သန်း
၅.၄၅ သန်း
Interest expense
-၃.၀၀ သန်း
-၂.၈၃ သန်း
-၂.၇၈ သန်း
-၂.၇၉ သန်း
Net interest expenses
၇.၂၇ သိန်း
၄.၅၁ သန်း
၃.၂၇ သန်း
၂.၆၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၆.၇၆ ကုဋေ
-၆.၈၅ ကုဋေ
-၉.၂၁ ကုဋေ
-၈.၀၃ ကုဋေ
Gain or loss from assets sale
-
-
၄.၈၇ သန်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ